what tier is semaglutide 2 - Nurse Discount Semaglutide vs Tirzepatide: Head-to-Head for

Headaches affect up to 25% of people taking semaglutide for weight loss

Diabetes GLP-1s Show Better Retention but Still Leak Demand GLP-1 therapies prescribed for type 2 diabetes demonstrate stronger patient retention than those indicated for obesity, but the market still faces substantial leakage

Find out the impact of embracing a high-fat, low-carb lifestyle on your health, weight, and well-being in our comprehensive guide.

22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.

June 2, 2026

Id also raise the question of whether the incretins and other GLP-1 agonists will ever be free of adverse GI symptoms, as it seems intrinsic to the drugs mechanism.